VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in miceXuemei Ou, Lei Chen, Wancheng Li et al.|International Immunopharmacology|2008Cited by 60
Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression during neoadjuvant therapy of non‑small cell lung cancer: A case report and literature reviewXinyi Li, Luwen Shi, Xun Wang et al.|Oncology Letters|2023Cited by 6
Huge heterogeneity of patient characteristics, treatment patterns, hospital costs exists in non-small cell lung cancer surgeries among different centers of China: A study of 5060 patients based on the Chinese national NSCLC outcome registry.Jian Zhou, Jun Wang, Aaron Jin et al.|Journal of Clinical Oncology|2016Cited by 0
Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression in neoadjuvant therapy for Non-Small Cell Lung Cancer: a case report and literature reviewXinyi Li, Luwen Shi, Xun Wang et al.|Research Square|2022Cited by 0